from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1751/-

LFCtreatmentdescriptionclass of inhibitor

-0.515

Amikacinug/mL Amikacintranslation

-2.140

Cap5-10ug/mL Capreomycintranslation

-2.423

Rox10-50 ug/mL Roxithromycintranslation

0.365

SM2-5 ug/mL Streptomycintranslation

-2.225

Tet5-10 ug/mL Tetracyclinetranslation

0.666

Rif0.2-5ug/mL Rifampicintranscription

0.622

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.142

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.557

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.534

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.484

Clofazimine10-13 ug/mL Clofaziminerespiration

0.220

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.730

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.295

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.467

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.210

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.188

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.111

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.177

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.530

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.494

KCN5-20 ug/mL Potassium cyaniderespiration

-0.045

NaN30.2-2 mM Sodium aziderespiration

0.105

Nigericin50 uM Nigericinrespiration

-0.659

TRC10-150 ug/mL Triclosanrespiration

0.098

TRZ10-25 ug/mL Thioridazinerespiration

-1.814

Valinomycin0.5-10 uM Valinomycinrespiration

0.057

ZnSO42 mM ZnSO4respiration

-0.684

menadione6-10 ug/mL Menadionerespiration

-0.511

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.160

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.622

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.546

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.251

NRP_1Non-replicating persistence stage 1dosRassociated

0.084

Amp0.2mg/mL AmpicillincellWall

0.512

Cephalexin20-100 ug/mL CephalexincellWall

0.435

Cerulenin0.32-5 ug/mL CerulenincellWall

1.035

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.622

EMB10-20 ug/mL EthambutolcellWall

0.852

Eta12-40 ug/mL EthionamidecellWall

0.508

INH0.2-0.4 ug/mL IsoniazidcellWall

0.648

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.620

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.529

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.084

BZA0.12 mg/mL BenzamidearomaticAmides

0.225

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.021

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.822

H2O24 mM hydrogen peroxideDNAdamaging

0.236

Levo10 ug/mL LevofloxacinDNAdamaging

0.721

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.383

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.220

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.718

UVUV-irradiationDNAdamaging

-0.091

ARP41-4 ug/mL Antitubercular compound ARP4?

0.194

Antimycin12.5-50 ug/mL Antimycin A?

-0.109

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.132

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.080

PA8240.2-2 ug/mL PA-824?

0.243

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.053

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.194

Verapamil50 uM Verapamil?

0.357

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.554

methoxatin10-20 ug/mL Methoxatin?